What is Duality?
Founded in 2016 and headquartered in Maplewood, New Jersey, Duality specializes in the development of the SecurePlus platform. The company operates at the intersection of cybersecurity, data science, and artificial intelligence, providing a robust framework for organizations to derive actionable insights from encrypted datasets. By enabling secure analysis without the need for data decryption, Duality addresses the fundamental tension between data utility and privacy. This unique value proposition has attracted a diverse range of investors, including venture capital firms, corporate strategic arms, and research-focused organizations, all of whom recognize the transformative potential of privacy-preserving computation in the modern digital economy.
How much funding has Duality raised?
Duality has raised a total of $56M across 4 funding rounds:
Unspecified
$4M
Series A
$16M
Series B
$30M
Unspecified
$6M
Unspecified (2018): $4M with participation from Team8
Series A (2019): $16M led by Hearst Ventures, Intel Capital, and Team8
Series B (2021): $30M supported by Euclidean Capital, LG Technology Ventures, and NAventures
Unspecified (2024): $6M featuring Advanced Research Projects Agency for Health
Key Investors in Duality
Team8
Team8 is a company-building venture group with deep domain expertise that creates companies and invests in firms specializing in enterprise technology, data, AI, and cybersecurity.
Hearst Ventures
Hearst is a global diversified media, information, and services company that delivers trusted content, data-driven insights, and technology-enabled services to businesses worldwide.
Intel Capital
Intel Capital is a division of Intel that invests in innovative startups targeting artificial intelligence, autonomous vehicles, cloud computing, and next-generation compute technologies.
What's next for Duality?
With the recent $6M injection, Duality is well-positioned to scale its operations and deepen its penetration into key sectors such as healthcare, financial services, and enterprise technology. The strategic focus will likely shift toward enhancing the scalability of the SecurePlus platform to handle larger, more complex datasets while maintaining high performance. Furthermore, the involvement of specialized entities like the Advanced Research Projects Agency for Health suggests a concerted effort to apply Duality's technology to high-stakes biomedical and health research. As the company continues to build out its ecosystem, it will likely prioritize strategic partnerships that facilitate broader adoption of its privacy-first AI solutions, ensuring that it remains at the forefront of the secure data collaboration market.
See full Duality company page
